NewsIn memory
What Rosalind Franklin's Story Can Help Us Understand About Ovarian Cancer
The scientist whose work helped reveal DNA's structure died of ovarian cancer in 1958 at age 37. Here is what that cancer means, explained calmly.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What the record shows
Rosalind Elsie Franklin was born in London on 25 July 1920. She became a chemist and X-ray crystallographer, and her diffraction work at King's College London, including the image known as Photo 51, provided crucial evidence for the double-helix structure of DNA.
The National Library of Medicine, which holds the Rosalind Franklin Papers, records what happened next in a single paragraph.
In the fall of 1956 Franklin was diagnosed with ovarian cancer. Over the following 18 months she underwent surgeries and other treatments. She had several periods of remission, during which she continued working in her laboratory and sought funding for her research team. She died in London on 16 April 1958.
She was 37. Across a 16-year career she published 19 articles on coals and carbons, 5 on DNA, and 21 on viruses.
That is the whole of what is known about her illness, and this page states nothing beyond it. Medicine in 1956 bears almost no resemblance to medicine now, so her case cannot be read as a guide to anyone's situation today. What her story does is point at a disease that is still hard to catch early.
What ovarian cancer is
NCI groups three cancers together because they arise in similar tissue and are treated the same way: ovarian epithelial cancer, fallopian tube cancer and primary peritoneal cancer.
The ovaries are a pair of organs about the size and shape of an almond, one on each side of the uterus. The fallopian tubes carry eggs from the ovaries to the uterus. The peritoneum is the tissue lining the abdominal wall and covering the organs inside it.
Cancer sometimes begins at the end of a fallopian tube near the ovary and spreads to the ovary. Primary peritoneal cancer starts in the peritoneum and has not spread there from anywhere else.
Less common types exist, including ovarian germ cell tumors and ovarian tumors of low malignant potential, sometimes called borderline tumors. Which type is present changes the plan. Our page on ovarian cancer types sets out the differences.
Why there is still no screening program
This is the part that connects 1956 to now, and it is uncomfortable.
NCI's screening summary carries a blunt heading: screening for ovarian cancer may not help a person live longer.
Three tests have been studied. Pelvic exams have not been shown to reduce deaths from the disease. Transvaginal ultrasound, in which a probe in the vagina builds a picture of the pelvic organs, has not been shown to reduce deaths either. The CA-125 blood test measures a substance released into the blood, raised in some ovarian cancers and also in other conditions.
Studies of CA-125 and transvaginal ultrasound used together also failed to reduce ovarian cancer deaths.
So there is no routine screening test for women at average risk. Seventy years after Franklin's diagnosis, the disease is still usually found because of symptoms.
When to get checked
NCI's own framing is stark: ovarian cancer may not cause early signs or symptoms, and when they do appear the cancer is often advanced.
The signs NCI lists are:
- Pain, swelling or a feeling of pressure in the abdomen or pelvis.
- A sudden or frequent urge to urinate.
- Trouble eating, or feeling full quickly.
- A lump in the pelvic area.
- Gas, bloating or constipation.
Read as a list, these are indistinguishable from an ordinary bad fortnight. The useful test is not which symptom, but how it behaves.
NCI's rule: if the signs get worse, or do not go away on their own, check with your doctor so any problem can be diagnosed and treated as early as possible.
In practice that means the pattern to act on is persistence. Bloating that is present most days for three weeks, feeling full after a few mouthfuls when that is new, or needing to urinate urgently and often without an infection. Not one bad week. Our page on ovarian cancer symptoms covers what an assessment involves.
Family history changes the calculation
Some ovarian, fallopian tube and primary peritoneal cancers are caused by inherited gene changes. NCI notes that women with an increased risk may consider surgery to lower it.
That is a decision with real consequences, and it is the reason genetic counseling exists as a distinct service. A family history of ovarian or breast cancer, particularly at young ages or on the same side of a family, is a reason to raise it. Our page on ovarian cancer risk factors sets out what raises and lowers risk.
The numbers now
The American Cancer Society projects 21,010 new US ovarian cancer cases and 12,450 deaths for 2026, and SEER carries that projection. Median age at diagnosis is 63. Franklin was 36 when she was diagnosed.
Five-year relative survival for cases from 2016 to 2022 is 52.0 percent overall. Split by how far the cancer had spread when found, it is 91.9 percent while confined to the ovary, 70.1 percent with regional lymph nodes involved, and 31.5 percent once it has spread to distant sites.
Twenty-two percent are found while still confined. Fifty-four percent are already distant.
In the mid-1970s, the earliest period SEER covers, five-year relative survival was around 34 percent. The improvement is real and modest, and it is nothing like the gains seen in some other cancers.
These are averages across a whole registry population. They describe a group, not a person, and they cannot say anything about an individual diagnosis.
What to keep in perspective
A death in 1958 says nothing about outcomes today. Surgery, chemotherapy, imaging and genetic testing have all changed beyond recognition.
Nor does one person's story indicate anything about anyone else's risk. Franklin's diagnosis at 36 was unusual then and would be unusual now.
The absence of a screening test is not an oversight. It is a finding: the tests studied did not reduce deaths, and offering them anyway would cause harm without benefit.
And the practical takeaway is small and unglamorous. Symptoms that persist beyond a few weeks are worth an appointment, and a family history is worth mentioning out loud.
Sources
- US National Library of Medicine, The Rosalind Franklin Papers: Biographical Overview — https://profiles.nlm.nih.gov/spotlight/kr/feature/biographical
- NCI PDQ, Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Screening (Patient Version) — https://www.cancer.gov/types/ovarian/patient/ovarian-screening-pdq
- NCI PDQ, Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (Patient Version) — https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq
- SEER Cancer Stat Facts, Ovarian Cancer — https://seer.cancer.gov/statfacts/html/ovary.html
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Ovarian cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.